We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Serum Albumin Levels Predict Pneumonia Severity

By LabMedica International staff writers
Posted on 30 Jan 2013
The prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia has been evaluated. More...


When serum albumin levels are measured within 24 hours of admission to the hospital, they can be correlated with the outcome of patients with community-acquired pneumonia (CAP).

Scientists at the University Hospital of Bellvitge (Barcelona, Spain) carried out a prospective cohort of adults with CAP requiring hospitalization from 1995 through 2011. Serum albumin results were obtained from the central laboratory database and were determined by a molecular absorption spectrometry utilizing bromocresol green. Pathogens in blood, normally sterile fluids, sputum, and other samples were investigated using standard microbiological procedures. Serum albumin levels were measured within 24 hours of admission. The primary end point was 30-day mortality.

During the study period, 3,463 patients with CAP required hospitalization. The median value of albumin was 31 g/L. As levels of serum albumin decrease, the risk of complications significantly increased. Decreased albumin levels were also significantly associated with prolonged time to reach clinical stability, prolonged hospital stay, intensive care unit (ICU) admission, the need for mechanical ventilation, and 30-day mortality. Hypoalbuminemia was documented in 1,307 (37.7%) patients, whose serum albumin was less than 30 g/L.

The authors concluded that hypoalbuminemia is frequent among hospitalized patients with CAP. Low serum albumin levels within 24 hours of hospital admission are significantly associated with increased risk of complications and poor outcome from CAP. Serum albumin is an objective and good prognostic marker in hospitalized adults with CAP. The study was published on December 31, 2012, in the Journal of Infection.

Related Links:

University Hospital of Bellvitge




New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.